Cibc Private Wealth Group, LLC Haemonetics Corp Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 445 shares of HAE stock, worth $39,364. This represents 0.0% of its overall portfolio holdings.
Number of Shares
445
Previous 395
12.66%
Holding current value
$39,364
Previous $32,000
9.38%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HAE
# of Institutions
333Shares Held
54MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$527 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$457 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$393 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$372 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$356 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.54B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...